Philamcare: health coverage and alleged concealment

Facts and context

Ernani Trinos applied for Philamcare coverage and answered no to a medical-history question concerning specified conditions. Philamcare approved his application and later extended the agreement. During the coverage period, he suffered a heart attack and was hospitalized for a month.

Philamcare refused benefits, claiming that the agreement was void because Trinos had concealed hypertension, diabetes, and asthma allegedly discovered during his confinement. His wife Julita paid the medical expenses. After further treatment and his death, she sued for reimbursement and damages.

The trial court ordered reimbursement and additional awards. The Court of Appeals maintained the reimbursement but deleted the damages awards and absolved Philamcare’s president, Dr. Benito Reverente. Philamcare then challenged its liability, arguing in part that an HMO agreement was not insurance and that the Insurance Code’s incontestability provision did not apply.

Issue

Could Philamcare avoid its reimbursement obligation through the asserted concealment and invalidation clause, given the application, contract terms, and absence of proper rescission or cancellation?

Ruling and doctrine

The Supreme Court denied Philamcare’s petition and affirmed the appellate decision. For the dispute before it, the health care agreement was in the nature of non-life insurance and a contract of indemnity: covered medical expenses had to be paid to the extent promised by the agreement.

The Court treated the challenged medical-history answer as substantially dependent on the applicant’s opinion or understanding, particularly because he was not a physician. An answer of that character, made in good faith without intent to deceive, did not avoid the agreement merely because it was inaccurate. The Court required the provider to establish the concealment defense by satisfactory and convincing evidence; an allegation alone was insufficient.

Philamcare had not properly rescinded the agreement before the action or fulfilled the cancellation conditions discussed in the decision. The Court also approved the trial court’s findings that the agreement’s own periods for contesting membership on the specified ailments had expired: twelve months for asthma and six months for diabetes or hypertension. Those contract periods must be distinguished from the statutory two-year life-insurance provision debated by the parties.

Ambiguous or doubtful limitations in a health care agreement were construed against the provider that drafted them and in favor of coverage. Julita was entitled to reimbursement as the person who actually incurred the expenses, notwithstanding Philamcare’s challenge to her marital status. The Supreme Court did not restore the damages deleted by the Court of Appeals.

Practice implications

Parao Law practice guidance

For physicians

• When a patient faces a coverage dispute, give a factual account of diagnosis, symptoms, treatment, and relevant history within an authorized disclosure process. Distinguish a previously diagnosed condition from a finding first established during the admission.
• Encourage accurate enrollment answers and correction of known errors. This decision does not authorize concealing a diagnosis or signing a misleading report.
• Preserve the dates and original medical records; a later diagnosis does not necessarily establish what an applicant knew when answering a form.

For lawyers

• Read the application question, the answer, investigation authorization, exclusions, and contest periods together. Establish what the applicant actually knew and represented.
• Check the alleged ground for avoidance and whether rescission or cancellation was legally and contractually effective.
• Identify who incurred the claimed expense and what reimbursement the agreement provides.

Limits of the ruling

The opinion addresses this health care agreement and record. Its discussion of good-faith answers involving opinion should not become a universal rule that fraudulent intent is necessary for every form of insurance concealment. Nor does the agreement’s particular contest period establish a fixed period for all HMO products. Current contracts and the applicable law must be read separately.